Tafamidis meglumine is an organoammonium salt obtained by combining tafamidis with one molar equivalent of 1-deoxy-1-(methylamino)-D-glucitol. Used for the amelioration of transthyretin-related hereditary amyloidosis. Among its listed roles, it functions as a central nervous system drug. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Vyndaqel, 1-deoxy-1-(methylazaniumyl)-D-glucitol 2-(3, 5-dichlorophenyl)-1 and 3-benzoxazole-6-carboxylate. Its PubChem CID is 24970412.
Tafamidis meglumine
| CAS No | 951395-08-7 |
|---|---|
| Molecular Formula | C21H24Cl2N2O8 |
| Molecular Weight | 503.3 g/mol |
| Synonyms | 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tafamidis meglumine is an organoammonium salt obtained by combining tafamidis with one molar equivalent of 1-deoxy-1-(methylamino)-D-glucitol. Used for the amelioration of transthyretin-related hereditary amyloidosis.
The listed CAS number is 951395-08-7.
The listed molecular formula is C21H24Cl2N2O8.
The listed molecular weight is 503.3 g/mol.
2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol.
The source lists Vyndaqel, 1-deoxy-1-(methylazaniumyl)-D-glucitol 2-(3, 5-dichlorophenyl)-1 and 3-benzoxazole-6-carboxylate.